Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER PURSUANT TO
RULES
13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Marc Forth, certify that:
| 1. | I have reviewed this Amendment No. 2 to the Annual Report on Form 10-K/A of AEON Biopharma, Inc.; and |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
| Dated: August 12, 2024 | By: | /s/ Marc Forth | |
| Name: | Marc Forth | ||
| Title: | Chief Executive Officer | ||
| (Principal Executive and Financial Officer) | |||